Eisai and UCL Reach First Scientific Milestone in Neurodegenerative Disease Drug Discovery and Development Collaboration
Validation of a novel therapeutic concept marks a first step towards a new therapy for the treatment of neurodegenerative disorders such as Alzheimer’s disease and related dementias.
The UCL Technology Fund (‘UCLTF’), which is dedicated to investing in intellectual property commercialisation opportunities arising from UCL’s world-class research base, has announced an investment of up to £1m in biopharmaceutical company, Freeline Therapeutics (‘Freeline’).
3-day CPD Accredited Negotiation Training for Small Businesses, Entrepreneurs, UCL Staff, Alumni and Post-graduate Students.
3-day CPD Accredited Leadership and Management Training for Small Businesses, Entrepreneurs, UCL Staff, Alumni and Post-graduate Students.
Are you looking to take your business international, have a great product or service or looking for new suppliers but have limited resources to do so?